radiopharmaceutical therapy

You have access
Landscape Analysis of Phase 2 and 3 Clinical Trials for Targeted Radionuclide Therapy
Erik Mittra and Lisa Bodei

Journal of Nuclear Medicine August 1, 2021, 62 (8) 1031-1032; DOI: https://doi.org/10.2967/jnumed.120.258103
You have access
Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies
Xinchi Hou, Julia Brosch, Carlos Uribe, Alessandro Desy, Guido Böning, Jean-Mathieu Beauregard, Anna Celler and Arman Rahmim

Journal of Nuclear Medicine July 1, 2021, 62 (7) 1006-1011; DOI: https://doi.org/10.2967/jnumed.120.254656
You have access
An improved ²¹¹At-labeled agent for PSMA-targeted alpha therapy
Ronnie C Mease, Choongmo Kang, Vivek Kumar, Sangeeta Ray, IL Minn, Mary Brummet, Kathleen Gabrielson, Yutian Feng, Andrew Park, Ana Kiess, George Sgouros, Ganesan Vaidyanathan, Michael Zalutsky and Martin G. Pomper

Journal of Nuclear Medicine June 4, 2021, jnumed.121.262098; DOI: https://doi.org/10.2967/jnumed.121.262098
You have access
Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
Richard L. Wahl, Panithaya Chareonthaitawee, Bonnie Clarke, Alexander Drzezga, Liza Lindenberg, Arman Rahmim, James Thackeray, Gary A. Ulaner, Wolfgang Weber, Katherine Zukotynski and John Sunderland

Journal of Nuclear Medicine January 1, 2021, 62 (1) 6-14; DOI: https://doi.org/10.2967/jnumed.120.253450
You have access
PARP-1–Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma
Hwan Lee, Aladdin Riad, Paul Martorano, Adam Mansfield, Minu Samanta, Vandana Batra, Robert H. Mach, John M. Maris, Daniel A. Pryma and Mehran Makvandi

Journal of Nuclear Medicine June 1, 2020, 61 (6) 850-856; DOI: https://doi.org/10.2967/jnumed.119.233965
You have access
Dose Deposits from ⁹⁰Y, ¹⁷⁷Lu, ¹¹¹In, and ¹⁶¹Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy
Elif Hindié, Paolo Zanotti-Fregonara, Michele A. Quinto, Clément Morgat and Christophe Champion

Journal of Nuclear Medicine May 1, 2016, 57 (5) 759-764; DOI: https://doi.org/10.2967/jnumed.115.170423
You have access
Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen
Ana P. Kiess, Il Minn, Ying Chen, Robert Hobbs, George Sgouros, Ronnie C. Mease, Mrudula Pullambhatla, Colette J. Shen, Catherine A. Foss and Martin G. Pomper

Journal of Nuclear Medicine September 1, 2015, 56 (9) 1401-1407; DOI: https://doi.org/10.2967/jnumed.115.155929
You have access
Preclinical Evaluation of ⁸⁶Y-Labeled Inhibitors of Prostate-Specific Membrane Antigen for Dosimetry Estimates
Sangeeta Ray Banerjee, Catherine A. Foss, Mrudula Pullambhatla, Yuchuan Wang, Senthamizhchelvan Srinivasan, Robert F. Hobbs, Kwamena E. Baidoo, Martin W. Brechbiel, Sridhar Nimmagadda, Ronnie C. Mease, George Sgouros and Martin G. Pomper

Journal of Nuclear Medicine April 1, 2015, 56 (4) 628-634; DOI: https://doi.org/10.2967/jnumed.114.149062
You have access
Radiobiologic Optimization of Combination Radiopharmaceutical Therapy Applied to Myeloablative Treatment of Non-Hodgkin Lymphoma
Robert F. Hobbs, Richard L. Wahl, Eric C. Frey, Yvette Kasamon, Hong Song, Peng Huang, Richard J. Jones and George Sgouros

Journal of Nuclear Medicine September 1, 2013, 54 (9) 1535-1542; DOI: https://doi.org/10.2967/jnumed.112.117952

Main menu

User menu

Search

radiopharmaceutical therapy